Literature DB >> 24219351

Negative, not positive symptoms predict the early therapeutic alliance in cognitive behavioral therapy for psychosis.

Esther Jung1, Martin Wiesjahn, Tania M Lincoln.   

Abstract

OBJECTIVE: The strength of therapeutic alliance is consistently associated with therapy outcome. The aim of this study was to identify relevant predictors for early therapeutic alliance in cognitive behavioral therapy for psychosis.
METHOD: Fifty-six patients with schizophrenia spectrum disorders were included in the analysis. Possible predictors (positive and negative symptoms, depression, insight, social functioning, theory of mind, and medication adherence) were assessed at baseline. Alliance was assessed after each therapy session.
RESULTS: Lower negative symptoms significantly predicted higher patient and therapist rated alliance.
CONCLUSIONS: The findings indicate that negative symptoms might be a barrier to the development of therapeutic alliance. Assumed underlying processes and practical implications are discussed.

Entities:  

Mesh:

Year:  2013        PMID: 24219351     DOI: 10.1080/10503307.2013.851425

Source DB:  PubMed          Journal:  Psychother Res        ISSN: 1050-3307


  5 in total

1.  A Longitudinal Analysis of Factors Associated with Therapeutic Alliances.

Authors:  Tyrone C Cheng; Celia C Lo
Journal:  Community Ment Health J       Date:  2018-01-09

2.  Study development and protocol for a cohort study examining the impact of baseline social cognition on response to treatment for people living with post-traumatic stress disorder.

Authors:  Chantelle Wiseman; Andrew D Lawrence; Jonathan I Bisson; James Hotham; Anke Karl; Stan Zammit
Journal:  Eur J Psychotraumatol       Date:  2022-07-12

3.  Functional Impairments and Theory of Mind Deficits in Schizophrenia: A Meta-analysis of the Associations.

Authors:  Élisabeth Thibaudeau; Caroline Cellard; Mélissa Turcotte; Amélie M Achim
Journal:  Schizophr Bull       Date:  2021-04-29       Impact factor: 9.306

4.  Optimising AVATAR therapy for people who hear distressing voices: study protocol for the AVATAR2 multi-centre randomised controlled trial.

Authors:  Philippa Garety; Clementine J Edwards; Thomas Ward; Richard Emsley; Mark Huckvale; Paul McCrone; Mar Rus-Calafell; Miriam Fornells-Ambrojo; Andrew Gumley; Gillian Haddock; Sandra Bucci; Hamish McLeod; Amy Hardy; Emmanuelle Peters; Inez Myin-Germeys; Thomas Craig
Journal:  Trials       Date:  2021-05-25       Impact factor: 2.279

5.  Theory of mind, emotion recognition, delusions and the quality of the therapeutic relationship in patients with psychosis - a secondary analysis of a randomized-controlled therapy trial.

Authors:  Stephanie Mehl; Klaus Hesse; Anna-Christine Schmidt; Martin W Landsberg; Daniel Soll; Andreas Bechdolf; Jutta Herrlich; Tilo Kircher; Stefan Klingberg; Bernhard W Müller; Georg Wiedemann; Andreas Wittorf; Wolfgang Wölwer; Michael Wagner
Journal:  BMC Psychiatry       Date:  2020-02-10       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.